Disclosed are e.g. 5-(tetrazolylalkyl, hydroxycarbamoylalkyl)imidazo[1,5-a]-pyridines, and methods of synthesis. Said compounds are useful as selective thromboxane synthetase inhibitors for the treatment of diseases such as cerebral ischaemia, shock, thrombosis and ischaemic heart disease.
本发明涉及例如5-(
四唑基烷基,羟基甲酰胺基烷基)
咪唑[1,5-a]-
吡啶化合物及其合成方法。所述化合物可用作选择性血栓素合酶
抑制剂,用于治疗诸如脑缺血、休克、血栓形成和缺血性心脏病等疾病。